TIBSOVO (ivosidenib tablets)
TIBSOVO is a prescription medicine used to treat: • acute myeloid leukemia (AML) with an isocitrate dehydrogenase-1 (IDH1) mutation • adults with bile duct cancer (cholangiocarcinoma)
Home | (ivosidenib tablets)
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient inquires under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
TIBSOVO (ivosidenib tablets)
Ivosidenib is approved to treat adults whose cancer has a certain mutation in the IDH1 gene, including: Acute myeloid leukemia, Cholangiocarcinoma (bile duct cancer). Ivosidenib is also being studied in the treatment of other types of cancer.
Tibsovo, A drug used alone or with other drugs to treat adults with certain types of acute myeloid leukemia or cholangiocarcinoma (a type of bile duct cancer) that have a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Tibsovo blocks the protein made by the mutated IDH1 gene, which may help keep cancer cells from growing. It is a type of enzyme inhibitor and a type of targeted therapy. Also called ivosidenib.
Ivosidenib, A drug used alone or with other drugs to treat adults with certain types of acute myeloid leukemia or cholangiocarcinoma (a type of bile duct cancer) that have a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Ivosidenib blocks the protein made by the mutated IDH1 gene, which may help keep cancer cells from growing. It is a type of enzyme inhibitor and a type of targeted therapy. Also called Tibsovo.
Drug (Brand / Generic): TIBSOVO / ivosidenib
Current Indications: acute myeloid leukemia or cholangiocarcinoma
Marketed by:: Servier Pharmaceuticals
Approval Date: 2018
Available as (Form & Strength): Tablets: 250 mg
Find Reference Updates
Alleviare Life Sciences
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “TIBSOVO (ivosidenib tablets)”.
Confirmation of the order for TIBSOVO (ivosidenib tablets) will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
We have delivered medicines to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand TIBSOVO (ivosidenib tablets). The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to TIBSOVO (ivosidenib tablets), they can inquire and find further information by sending their inquiries to ALS.
We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.
Kindly reach out to us for TIBSOVO (ivosidenib tablets) price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.